Bregt S Kappelhoff

Pharmacokinetic Parameters of Nevirapine and Efavirenz in Relation to Antiretroviral Efficacy

Frank van Leth, Bregt S Kappelhoff, David W. Johnson et al. · AIDS Research and Human Retroviruses · 2006 · 81 citations

Population pharmacokinetics of lopinavir in combination with ritonavir in HIV‐1‐infected patients

Kristel M. L. Crommentuyn, Bregt S Kappelhoff, Jan W. Mulder et al. · British Journal of Clinical Pharmacology · 2005 · 71 citations · Full text

Ritonavir Plasma Concentrations, Pharmacotherapy, Population Pharmacokinetics +23

Simple and rapid method for the simultaneous determination of the non-nucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma using liquid chromatography

Bregt S Kappelhoff, Hilde Rosing, Alwin D. R. Huitema et al. · Journal of Chromatography B · 2003 · 58 citations

Diagnostic Virology, Medicine, Drug Discovery +14

Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals

Bregt S Kappelhoff, Alwin D. R. Huitema, Zeynep Yalva et al. · Clinical Pharmacokinetics · 2005 · 53 citations

Hiv-1-infected Individuals, Human Retrovirus, Unselected Cohort +10

Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV‐1‐infected patients

Bregt S Kappelhoff, Alwin D. R. Huitema, Kristel M. L. Crommentuyn et al. · British Journal of Clinical Pharmacology · 2004 · 39 citations · Full text